科濟藥業－Ｂ(02171.HK)公布2023年止年度業績，錄得虧損由上年度8.92億人民幣(下同)，收窄至7.48億元，每股虧損1.34元。不派末期息。年內並無產生收益。
《公司業績》科濟藥業(02171.HK)全年虧損收窄至7.48億人民幣
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.